Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
Library and Information Services for the East Metropolitan Health Service and the South Metropolitan Health Service banner Library and Information Services for the East Metropolitan Health Service and the South Metropolitan Health Service home Library and Information Services for the East Metropolitan Health Service and the South Metropolitan Health Service logo

COVID-19

News and Recent Papers

Covid-19: Colleges publish guidance after patients attend emergency departments with vaccine concerns - BMJ - 13 April 2021  ...The Guidance

Joint statement from ATAGI and THANZ on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca

Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT) - British Society for Haematology - May 2021

ScienceDaily Vaccines News     |     Nature - News and Articles     |     The Scientist  COVID-19 Updates

Powerful new COVID-19 vaccine shows 90% efficacy, could boost world’s supply [Novavax] - Science - 14 June 2021

Medico-legal considerations of mandatory COVID-19 vaccination for high risk workers - MJA [Medical Journal of Australia] - 11 June 2021

COVID-19 Vaccination of Health Care Personnel as a Condition of Employment. A Logical Addition to Institutional Safety Programs - JAMA - 7 June 2021

The Critical Public Health Value of Vaccines. Tackling Issues of Access and Hesitancy: Proceedings of a Workshop - National Academies of Sciences, Engineering, and Medicine [US] - 2021

Editorial. Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine - JAMA - 30 April 2021
...US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 - JAMA - 30 April 2021

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study - Lancet - 27 April 2021

COVID vaccines: time to confront anti-vax aggression - Nature - 27 April 2021

Understanding and Communicating about COVID-19 Vaccine Efficacy, Effectiveness, and Equity - [US] National Academies of Sciences, Engineering, and Medicine - 2021

Editorial. Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup - NEJM - 22 April 2021

Preparing for the Future — Nanobodies for Covid-19? - NEJM - 22 April 2021

An Uncertain Public — Encouraging Acceptance of Covid-19 Vaccines - NEJM - 22 April 2021

Covid-19: Is the UK heading towards mandatory vaccination of healthcare workers? - BMJ - 21 April 2021

Vaccine Breakthrough Infections with SARS-CoV-2 Variants - NEJM - 21 April 2021

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 - NEJM - 21 April 2021

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons - NEJM - 21 April 2021

The Blood-Clot Problem Is Multiplying. So are theories to explain it - The Atlantic - 17 April 2021

COVID vaccines and blood clots: five key questions - Nature - 16 April 2021

Rare clotting disorder: tiny risk, big questions - InSight - 19 April 2021

Blood Clot Risk from COVID-19 Higher than After Vaccines: Study - The Scientist - 16 April 2021

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia - NEJM - 16 April 2021

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination - NEJM - 16 April 2021

Covid-19: EU investigates four reports of blood clots after Janssen vaccine - BMJ - 13 April 2021

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination - NEJM - 9 April 2021

No Cure without Care — Soothing Science Skepticism - NEJM - 15 April 2021
...Escaping Catch-22 — Overcoming Covid Vaccine Hesitancy - NEJM - 8 April 2021

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - NEJM - 14 April 2021

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection - NEJM - 14 April 2021

How could a COVID vaccine cause blood clots? Scientists race to investigate - Nature - 9 April 2021

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination - NEJM - 9 April 2021

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination - NEJM - 9 April 2021

News - Communicating the potential benefits and harms of the Astra-Zeneca COVID-19 vaccine - Winton Centre for Risk and Evidence Communication, University of Cambridge 

Use of the AstraZeneca COVID-19 vaccine: JCVI statement. Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine - England. Department of Health and Social Care - 7 April 2021

Why is it so hard to investigate the rare side effects of COVID vaccines? - Nature - 1 April 2021

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study - Lancet - 27 March 2021

What scientists do and don’t know about the Oxford–AstraZeneca COVID vaccine - Nature - 24 March 2021

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California - NEJM - 23 March 2021

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis - AstraZeneca - 22 March 2021

COVID-19 Vaccines vs Variants - Determining How Much Immunity Is Enough - JAMA - 17 March 2021

Innovators target vaccines for variants and shortages in global South - Nature - 17 March 2021

CDC Interim Recommendations for Fully Vaccinated People. An Important First Step - JAMA - 10 March 2021

COVID-19 Vaccine Combos Aim to Boost Immunity - The Scientist - 9 March 2021

Acute Allergic Reactions to mRNA COVID-19 Vaccines. Research letter - JAMA - 8 March 2021

What Do Vaccine Efficacy Numbers Actually Mean? - New York Times - 3 March 2021

COVID vaccination studies: plan now to pool data, or be bogged down in confusion - Nature - 3 March 2021

Sex Differences in Immune Responses to Viral Infection - The Scientist - 1 Mar 2021

Q&A: New Trials Tackle COVID-19 Vaccines in Pregnancy - The Scientist - 25 February 2021

COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee - World Allergy Organ J - February 2021

Why COVID vaccines are so difficult to compare. Despite the widespread roll-out of several vaccines, it could be months before they can be ranked - Nature - 23 February 2021

Maintaining Safety with SARS-CoV-2 Vaccines - NEJM - 18 Feb 2021

COVID-19 Vaccines for Pregnant Moms May Protect Newborns - The Scientist - 17 February 2021

COVID vaccines and safety: what the research says - Nature - 16 Feb 2021

How ‘killer’ T cells could boost COVID immunity in face of new variants - Nature - 12 Feb 2021

Pfizer’s COVID-19 Vaccine Reduces Viral Load: Study - The Scientist - 10 Feb 2021

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers - JAMA - 11 Feb 2021

Variant-proof vaccines — invest now for the next pandemic - Nature - 8 Feb 2021

How were researchers able to develop COVID-19 vaccines so quickly? - University of Chicago News - 5 Feb 2021

Will Delaying Vaccine Doses Cause a Coronavirus Escape Mutant? - Scientist - 4 Feb 2021

A New Vaccine to Battle Covid-19. Editorial & Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - NEJM - 4 February 2021

Strategies for Building COVID-19 Vaccine Confidence - National Academies of Sciences Engineering Medicine [US] - 3 February 2021

Nudging for other's sake: An ethical analysis of the legitimacy of nudging healthcare workers to accept influenza immunization - Bioethics - Jan 2021

Inside the B.1.1.7 Coronavirus Variant - NY Times - 18 Jan 2021